-
平臺編號：bio-49398
-
國際編號：ATCC VR-2377
-
拉丁屬名： Rotavirus reassortant
-
規(guī)格：frozen
-
用途：ATCC原裝進口
-
服務費用：
加載中…… - 訂購
-
注意事項：僅用于科學研究或者工業(yè)應用等非醫(yī)療目的不可用于人類或動物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準）
中文名稱暫無
ATCC? Number:VR-2377?
Classification: Reoviridae, Rotavirus
Agent: Rotavirus reassortant
Strain: WI79-4
Depositors: Wistar Institute of Anatomy and Biology
Biosafety Level:2
Shipped: frozen
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Host Organism : Vero cells (ATCCCCL-81) MA-104 cells (ATCCCRL-2378); CV-1 cells (ATCCCCL-70); Vero cells (ATCCCCL-81)
Incubation : Temperature: 36.0°C Duration: 1-4 days at 37C
Effect : Yes, in vitro effects: Cytopathic effects (cell rounding and shedding of cells)
Store at : -70C
Comments : reassortant of WI79, isolated from a human infant, and WC3, isolated from a calf -70C
References : 40170: Clark HF, et al. Rotavirus reassortant vaccine. US Patent 5,626,851 dated May 6 1997
Classification: Reoviridae, Rotavirus
Agent: Rotavirus reassortant
Strain: WI79-4
Depositors: Wistar Institute of Anatomy and Biology
Biosafety Level:2
Shipped: frozen
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Host Organism : Vero cells (ATCCCCL-81) MA-104 cells (ATCCCRL-2378); CV-1 cells (ATCCCCL-70); Vero cells (ATCCCCL-81)
Incubation : Temperature: 36.0°C Duration: 1-4 days at 37C
Effect : Yes, in vitro effects: Cytopathic effects (cell rounding and shedding of cells)
Store at : -70C
Comments : reassortant of WI79, isolated from a human infant, and WC3, isolated from a calf -70C
References : 40170: Clark HF, et al. Rotavirus reassortant vaccine. US Patent 5,626,851 dated May 6 1997
